Licensing and decisions on public health use of a vaccine rely on a robust development program that permits a risk-benefit assessment of the product in the target population Tropical diseases are an emerging threat, not only in their original endemic regions but also outside of those. Adrian Wildfire and Bruno Speder at hvivo analyse vaccine solutions for tropical disease.